BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 84 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $746,400 | -30.5% | 40,000 | -20.0% | 0.52% | -51.5% |
| Q4 2022 | $1,074,000 | +81.7% | 50,000 | 0.0% | 1.06% | +75.1% |
| Q3 2022 | $591,000 | -41.9% | 50,000 | 0.0% | 0.61% | +104.7% |
| Q4 2021 | $1,017,000 | -4.2% | 50,000 | +42.9% | 0.30% | +9.6% |
| Q3 2021 | $1,062,000 | +46.1% | 35,000 | +40.0% | 0.27% | +37.1% |
| Q2 2021 | $727,000 | -32.6% | 25,000 | 0.0% | 0.20% | -45.9% |
| Q1 2021 | $1,079,000 | -6.6% | 25,000 | 0.0% | 0.36% | -24.5% |
| Q4 2020 | $1,155,000 | +33.2% | 25,000 | +25.0% | 0.48% | +14.8% |
| Q3 2020 | $867,000 | -34.6% | 20,000 | -20.0% | 0.42% | -43.8% |
| Q2 2020 | $1,325,000 | – | 25,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |